Event Capital Strategies

What Event Capital Strategies does

Event Capital Strategies is a privately held, New York-based private equity firm that invests in the healthcare sector. The firm pursues a thematic investment strategy, targeting large, consolidated healthcare markets it believes can be disrupted through new technologies and business-model innovation, with explicit focus areas in Medication Management, Orthopedics, Life Sciences, Diagnostics, and Healthcare IT & Services. Its disclosed portfolio includes Spectrum Vascular, Piccolo Medical, St. Joseph Recovery, and Harlow MP, and investments are structured either as standalone businesses or as the simultaneous acquisition of multiple companies designed to be combined into a single platform investment.

The firm is led by Managing Partners Richard Fay and Christopher Yamamoto, each with over 20 years of private equity, M&A, and strategy experience, alongside Howard Jaslow as an Operating Partner. It is supported by an operating-partner bench of domain specialists—a medical device CEO, a pharmaceutical CFO, a contract manufacturing senior executive, and a physician/hospital chairman with Middle East institutional investing experience—who provide hands-on strategic and functional support to portfolio companies, can stand up businesses and carveouts, and can temporarily fill management gaps.

Event Capital's revenue mechanics are typical of a small, partner-led private equity firm: returns derive from executing the investment strategy and from operational, managerial, and financial improvements implemented during the ownership period, supplemented by professional services and managed services revenue streams tied to portfolio company operations. Pricing, fund size, AUM, and any limited partner base are not publicly disclosed. The firm employs 1-10 people, sources deals primarily through its global operating-partner network and direct outreach, and is independently owned by its founding partners.

Name

Event Capital Strategies

Legal name

Event Capital Strategies

Website

https://eventcapitalstrategies.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Event Capital Strategies is a New York-based, privately held private equity firm that invests in healthcare companies across medication management, orthopedics, life sciences, diagnostics, and healthcare IT, supporting portfolio investments through a bench of healthcare and pharmaceutical operating partners.

Ownership category

akta.pro rank

Product category

Healthcare Private Equity

NAICS

Portfolio Management and Investment Advice (52394), Other Financial Investment Activities (5239)

SIC

Investment Advice (6282)

akta.pro primary industry

Late-Stage Venture Capital (Series C+) (FSANAAAC)

akta.pro secondary industry

Capital Raising Advisory (Debt/Equity/Private Capital) (BPAHADAG)

Keywords

• Healthcare private equity
• Healthcare investments
• Platform investments
• Operating partners
• Medical technology investments

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Private Equity Investment Returns: Returns are derived from execution of the investment strategy and fundamental improvements—operational, managerial, financial—enabled during ownership period. The firm seeks to create and/or enhance competitive differentiation and substantially boost profitability across portfolio companies.
2. Portfolio Company Operations: Hands-on strategic and functional support to portfolio companies, with operating partners who may temporarily fill management gaps when needed. Provides standby support alongside management as partners.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels2 records

Core offering

Event Capital Strategies is a private equity firm that invests broadly in the healthcare sector, targeting large, consolidated markets that can be disrupted through new technologies and business model innovation. The firm acquires and operates healthcare companies—either as standalone businesses or by simultaneously acquiring multiple companies to form platform investments—while providing hands-on strategic and operational support through a network of operating partners from leading healthcare and pharmaceutical companies.

Product overview

Event Capital Strategies is a private equity and investment firm focused on healthcare. Rather than offering a unified software product or platform, the company operates as an investment vehicle that acquires and manages portfolio companies across healthcare verticals including Medication Management, Orthopedics, Life Sciences, Diagnostics, and Healthcare IT & Services. The firm provides investment capital and operational support to portfolio companies such as Spectrum Vascular, Piccolo Medical, SJRC, and HarlowMP. There are no discrete software products, modules, or named service offerings sold to external customers.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Platform Investments
• Operating Partner Support Services
• Carveout and Business Standup Services
• Operational Improvement Program

Quantifiable outcome

• Substantially boost profitability of portfolio companies

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Avista Capital Partners: Healthcare-focused private equity firm that acquires and operates healthcare businesses. Direct comparable to ECS given similar mid-market healthcare thesis, operating partner involvement, and platform-build strategy.
• Linden Capital Partners: Healthcare-dedicated middle-market PE firm investing in medical products, specialty services, and pharma services. Closely comparable to ECS in sub-sector focus and platform construction approach.
• Frazier Healthcare Partners: Dedicated healthcare PE firm with both buyout and growth strategies across life sciences, medical devices, and healthcare services. Directly comparable investment focus and mid-market orientation.
• Welsh, Carson, Anderson & Stowe: Healthcare and technology-focused PE firm with deep healthcare investing franchise. Comparable in sector specialization and operating-partner-led value creation model, though at significantly larger AUM.
• Ampersand Capital Partners: Specialty PE firm focused on life sciences, diagnostics, and healthcare. Direct comparable given niche healthcare thesis, mid-market check size, and sector-specialist operator network.
• Health Enterprise Partners: Healthcare-focused growth equity firm investing in healthcare services and IT companies. Direct comparable given concentrated healthcare focus, operating partner model, and mid-market orientation.

Broad incumbents

• Arsenal Capital Partners: Middle-market PE firm with significant healthcare and industrials investing practice. Comparable platform-build approach in healthcare verticals, though operates at larger fund size and broader sector mandate.
• New Mountain Capital: Large PE firm with substantial healthcare services and healthcare IT franchise. Comparable in healthcare disruption thesis and operating-partner involvement, though at materially larger scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/eventcapitalstrategies

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Event Capital Strategies